TY - JOUR AU - Haggar, F. A. AU - Boushey, R. P. PY - 2009 DA - 2009// TI - Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors JO - Clin Colon Rectal Surg VL - 22 UR - https://doi.org/10.1055/s-0029-1242458 DO - 10.1055/s-0029-1242458 ID - Haggar2009 ER - TY - JOUR AU - Ciasca, G. AU - Papi, M. AU - Minelli, E. AU - Palmieri, V. AU - Spirito, M. PY - 2016 DA - 2016// TI - Changes in cellular mechanical properties during onset or progression of colorectal cancer JO - World J Gastroenterol VL - 22 UR - https://doi.org/10.3748/wjg.v22.i32.7203 DO - 10.3748/wjg.v22.i32.7203 ID - Ciasca2016 ER - TY - JOUR AU - Ernst, M. AU - Putoczki, T. L. PY - 2013 DA - 2013// TI - Targeting IL-11 signaling in colon cancer JO - Oncotarget VL - 4 UR - https://doi.org/10.18632/oncotarget.1410 DO - 10.18632/oncotarget.1410 ID - Ernst2013 ER - TY - JOUR AU - Bashir, B. a. b. a. r. AU - Snook, A. d. a. m. E. PY - 2017 DA - 2017// TI - Immunotherapy regimens for metastatic colorectal carcinomas JO - Human Vaccines & Immunotherapeutics VL - 14 UR - https://doi.org/10.1080/21645515.2017.1397244 DO - 10.1080/21645515.2017.1397244 ID - Bashir2017 ER - TY - JOUR AU - Song, L. AU - Li, Y. AU - He, B. AU - Gong, Y. PY - 2015 DA - 2015// TI - Development of small molecules targeting the Wnt signaling pathway in Cancer stem cells for the treatment of colorectal Cancer JO - Clin Colorectal Cancer VL - 14 UR - https://doi.org/10.1016/j.clcc.2015.02.001 DO - 10.1016/j.clcc.2015.02.001 ID - Song2015 ER - TY - JOUR AU - Laarhoven, H. W. AU - Punt, C. J. PY - 2004 DA - 2004// TI - Systemic treatment of advanced colorectal carcinoma JO - Eur J Gastroenterol Hepatol VL - 16 UR - https://doi.org/10.1097/00042737-200403000-00006 DO - 10.1097/00042737-200403000-00006 ID - Laarhoven2004 ER - TY - JOUR AU - Goldberg, R. M. AU - Sargent, D. J. AU - Morton, R. F. AU - Fuchs, C. S. AU - Ramanathan, R. K. AU - Williamson, S. K. AU - Findlay, B. P. AU - Pitot, H. C. AU - Alberts, S. R. PY - 2004 DA - 2004// TI - A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.09.046 DO - 10.1200/JCO.2004.09.046 ID - Goldberg2004 ER - TY - JOUR AU - Tan, S. AU - Peng, X. AU - Peng, W. AU - Zhao, Y. AU - Wei, Y. PY - 2015 DA - 2015// TI - Enhancement of oxaliplatin-induced cell apoptosis and tumor suppression by 3-methyladenine in colon cancer JO - Oncol Lett VL - 9 UR - https://doi.org/10.3892/ol.2015.2996 DO - 10.3892/ol.2015.2996 ID - Tan2015 ER - TY - JOUR AU - Grivennikov, S. AU - Karin, E. AU - Terzic, J. AU - Mucida, D. AU - Yu, G. Y. AU - Vallabhapurapu, S. AU - Scheller, J. AU - Rose-John, S. AU - Cheroutre, H. AU - Eckmann, L. PY - 2009 DA - 2009// TI - IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer JO - Cancer Cell VL - 15 UR - https://doi.org/10.1016/j.ccr.2009.01.001 DO - 10.1016/j.ccr.2009.01.001 ID - Grivennikov2009 ER - TY - JOUR AU - Grivennikov, S. I. AU - Karin, M. PY - 2011 DA - 2011// TI - Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.140145 DO - 10.1136/ard.2010.140145 ID - Grivennikov2011 ER - TY - JOUR AU - Ernst, M. AU - Thiem, S. AU - Nguyen, P. M. AU - Eissmann, M. AU - Putoczki, T. L. PY - 2014 DA - 2014// TI - Epithelial gp130/Stat3 functions: an intestinal signaling node in health and disease JO - Semin Immunol VL - 26 UR - https://doi.org/10.1016/j.smim.2013.12.006 DO - 10.1016/j.smim.2013.12.006 ID - Ernst2014 ER - TY - JOUR AU - Howlett, M. AU - Menheniott, T. R. AU - Judd, L. M. AU - Giraud, A. S. PY - 2009 DA - 2009// TI - Cytokine signalling via gp130 in gastric cancer JO - Biochim Biophys Acta VL - 1793 UR - https://doi.org/10.1016/j.bbamcr.2009.07.009 DO - 10.1016/j.bbamcr.2009.07.009 ID - Howlett2009 ER - TY - JOUR AU - Nguyen, P. M. AU - Putoczki, T. L. AU - Ernst, M. PY - 2015 DA - 2015// TI - STAT3-activating cytokines: a therapeutic opportunity for inflammatory bowel disease? JO - J Interf Cytokine Res VL - 35 UR - https://doi.org/10.1089/jir.2014.0225 DO - 10.1089/jir.2014.0225 ID - Nguyen2015 ER - TY - JOUR AU - Garbers, C. AU - Hermanns, H. M. AU - Schaper, F. AU - Muller-Newen, G. AU - Grotzinger, J. AU - Rose-John, S. AU - Scheller, J. PY - 2012 DA - 2012// TI - Plasticity and cross-talk of interleukin 6-type cytokines JO - Cytokine Growth Factor Rev VL - 23 UR - https://doi.org/10.1016/j.cytogfr.2012.04.001 DO - 10.1016/j.cytogfr.2012.04.001 ID - Garbers2012 ER - TY - JOUR AU - Lokau, J. AU - Garbers, C. PY - 2018 DA - 2018// TI - The length of the interleukin-11 receptor stalk determines its capacity for classic signaling JO - J Biol Chem VL - 293 UR - https://doi.org/10.1074/jbc.RA118.001879 DO - 10.1074/jbc.RA118.001879 ID - Lokau2018 ER - TY - JOUR AU - Xu, D. H. AU - Zhu, Z. AU - Wakefield, M. R. AU - Xiao, H. AU - Bai, Q. AU - Fang, Y. PY - 2016 DA - 2016// TI - The role of IL-11 in immunity and cancer JO - Cancer Lett VL - 373 UR - https://doi.org/10.1016/j.canlet.2016.01.004 DO - 10.1016/j.canlet.2016.01.004 ID - Xu2016 ER - TY - JOUR AU - Bromberg, J. PY - 2002 DA - 2002// TI - Stat proteins and oncogenesis JO - J Clin Invest VL - 109 UR - https://doi.org/10.1172/JCI0215617 DO - 10.1172/JCI0215617 ID - Bromberg2002 ER - TY - JOUR AU - Yu, H. AU - Pardoll, D. AU - Jove, R. PY - 2009 DA - 2009// TI - STATs in cancer inflammation and immunity: a leading role for STAT3 JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2734 DO - 10.1038/nrc2734 ID - Yu2009 ER - TY - JOUR AU - Kitamura, H. AU - Onodera, Y. AU - Murakami, S. AU - Suzuki, T. AU - Motohashi, H. PY - 2017 DA - 2017// TI - IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model JO - Oncogene VL - 36 UR - https://doi.org/10.1038/onc.2017.236 DO - 10.1038/onc.2017.236 ID - Kitamura2017 ER - TY - JOUR AU - Ernst, M. AU - Putoczki, T. L. PY - 2014 DA - 2014// TI - Molecular pathways: IL11 as a tumor-promoting cytokine-translational implications for cancers JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2492 DO - 10.1158/1078-0432.CCR-13-2492 ID - Ernst2014 ER - TY - JOUR AU - Yoshizaki, A. AU - Nakayama, T. AU - Yamazumi, K. AU - Yakata, Y. AU - Taba, M. AU - Sekine, I. PY - 2006 DA - 2006// TI - Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells JO - Int J Oncol VL - 29 ID - Yoshizaki2006 ER - TY - JOUR AU - Putoczki, T. L. AU - Thiem, S. AU - Loving, A. AU - Busuttil, R. A. AU - Wilson, N. J. AU - Ziegler, P. K. AU - Nguyen, P. M. AU - Preaudet, A. AU - Farid, R. AU - Edwards, K. M. PY - 2013 DA - 2013// TI - Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically JO - Cancer Cell VL - 24 UR - https://doi.org/10.1016/j.ccr.2013.06.017 DO - 10.1016/j.ccr.2013.06.017 ID - Putoczki2013 ER - TY - JOUR AU - Parish, S. J. AU - Gillespie, J. A. PY - 2017 DA - 2017// TI - The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms JO - Postgrad Med VL - 129 UR - https://doi.org/10.1080/00325481.2017.1281083 DO - 10.1080/00325481.2017.1281083 ID - Parish2017 ER - TY - JOUR AU - Li, H. AU - Xiao, H. AU - Lin, L. AU - Jou, D. AU - Kumari, V. AU - Lin, J. AU - Li, C. PY - 2014 DA - 2014// TI - Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface JO - J Med Chem VL - 57 UR - https://doi.org/10.1021/jm401144z DO - 10.1021/jm401144z ID - Li2014 ER - TY - JOUR AU - Wu, X. AU - Cao, Y. AU - Xiao, H. AU - Li, C. AU - Lin, J. PY - 2016 DA - 2016// TI - Bazedoxifene as a novel GP130 inhibitor for pancreatic Cancer therapy JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0921 DO - 10.1158/1535-7163.MCT-15-0921 ID - Wu2016 ER - TY - JOUR AU - Chua, A. C. AU - Klopcic, B. R. AU - Ho, D. S. AU - Fu, S. K. AU - Forrest, C. H. AU - Croft, K. D. AU - Olynyk, J. K. AU - Lawrance, I. C. AU - Trinder, D. PY - 2013 DA - 2013// TI - Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0078850 DO - 10.1371/journal.pone.0078850 ID - Chua2013 ER - TY - JOUR AU - Kugimiya, N. AU - Nishimoto, A. AU - Hosoyama, T. AU - Ueno, K. AU - Takemoto, Y. AU - Harada, E. AU - Enoki, T. AU - Hamano, K. PY - 2017 DA - 2017// TI - JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer JO - Oncol Lett VL - 14 ID - Kugimiya2017 ER - TY - JOUR AU - Kelland, L. PY - 2007 DA - 2007// TI - The resurgence of platinum-based cancer chemotherapy JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2167 DO - 10.1038/nrc2167 ID - Kelland2007 ER - TY - JOUR AU - Chou, T. C. PY - 2010 DA - 2010// TI - Drug combination studies and their synergy quantification using the Chou-Talalay method JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-1947 DO - 10.1158/0008-5472.CAN-09-1947 ID - Chou2010 ER - TY - JOUR AU - Ren, L. AU - Wang, X. AU - Dong, Z. AU - Liu, J. AU - Zhang, S. PY - 2013 DA - 2013// TI - Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-013-0634-4 DO - 10.1007/s12032-013-0634-4 ID - Ren2013 ER - TY - JOUR AU - Lay, V. AU - Yap, J. AU - Sonderegger, S. AU - Dimitriadis, E. PY - 2012 DA - 2012// TI - Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3 JO - Int J Oncol VL - 41 UR - https://doi.org/10.3892/ijo.2012.1486 DO - 10.3892/ijo.2012.1486 ID - Lay2012 ER - TY - JOUR AU - Paul, S. R. AU - Bennett, F. AU - Calvetti, J. A. AU - Kelleher, K. AU - Wood, C. R. AU - O'Hara, R. M. AU - Leary, A. C. AU - Sibley, B. AU - Clark, S. C. AU - Williams, D. A. PY - 1990 DA - 1990// TI - Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine JO - Proc Natl Acad Sci U S A VL - 87 UR - https://doi.org/10.1073/pnas.87.19.7512 DO - 10.1073/pnas.87.19.7512 ID - Paul1990 ER - TY - JOUR AU - Schafer, S. AU - Viswanathan, S. AU - Widjaja, A. A. AU - Lim, W. W. AU - Moreno-Moral, A. AU - DeLaughter, D. M. AU - Ng, B. AU - Patone, G. AU - Chow, K. AU - Khin, E. PY - 2017 DA - 2017// TI - IL-11 is a crucial determinant of cardiovascular fibrosis JO - Nature VL - 552 UR - https://doi.org/10.1038/nature24676 DO - 10.1038/nature24676 ID - Schafer2017 ER - TY - JOUR AU - Davidson, A. J. AU - Freeman, S. A. AU - Crosier, K. E. AU - Wood, C. R. AU - Crosier, P. S. PY - 1997 DA - 1997// TI - Expression of murine interleukin 11 and its receptor alpha-chain in adult and embryonic tissues JO - Stem Cells VL - 15 UR - https://doi.org/10.1002/stem.150119 DO - 10.1002/stem.150119 ID - Davidson1997 ER - TY - JOUR AU - Wu, J. AU - Wang, Y. AU - Xu, X. AU - Cao, H. AU - Sahengbieke, S. AU - Sheng, H. AU - Huang, Q. AU - Lai, M. PY - 2016 DA - 2016// TI - Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer JO - Carcinogenesis VL - 37 UR - https://doi.org/10.1093/carcin/bgw029 DO - 10.1093/carcin/bgw029 ID - Wu2016 ER - TY - JOUR AU - Winship, A. AU - Sinderen, M. AU - Rainczuk, K. AU - Dimitriadis, E. PY - 2017 DA - 2017// TI - Therapeutically blocking Interleukin-11 receptor-alpha enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.15187 DO - 10.18632/oncotarget.15187 ID - Winship2017 ER - TY - JOUR AU - Cardo-Vila, M. AU - Marchio, S. AU - Sato, M. AU - Staquicini, F. I. AU - Smith, T. L. AU - Bronk, J. K. AU - Yin, G. AU - Zurita, A. J. AU - Sun, M. AU - Behrens, C. PY - 2016 DA - 2016// TI - Interleukin-11 receptor is a candidate target for ligand-directed therapy in lung Cancer: analysis of clinical samples and BMTP-11 preclinical activity JO - Am J Pathol VL - 186 UR - https://doi.org/10.1016/j.ajpath.2016.04.013 DO - 10.1016/j.ajpath.2016.04.013 ID - Cardo-Vila2016 ER - TY - JOUR AU - Li, H. AU - Yang, B. B. PY - 2013 DA - 2013// TI - Friend or foe: the role of microRNA in chemotherapy resistance JO - Acta Pharmacol Sin VL - 34 UR - https://doi.org/10.1038/aps.2013.35 DO - 10.1038/aps.2013.35 ID - Li2013 ER - TY - JOUR AU - Rolfo, C. AU - Fanale, D. AU - Hong, D. S. AU - Tsimberidou, A. M. AU - Piha-Paul, S. A. AU - Pauwels, P. AU - Meerbeeck, J. P. AU - Caruso, S. AU - Bazan, V. AU - Cicero, G. PY - 2014 DA - 2014// TI - Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer JO - Curr Pharm Biotechnol VL - 15 UR - https://doi.org/10.2174/1389201015666140519123219 DO - 10.2174/1389201015666140519123219 ID - Rolfo2014 ER - TY - JOUR AU - Fojo, T. PY - 2007 DA - 2007// TI - Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs JO - Drug Resist Updat VL - 10 UR - https://doi.org/10.1016/j.drup.2007.02.002 DO - 10.1016/j.drup.2007.02.002 ID - Fojo2007 ER - TY - JOUR AU - Yan, D. AU - Tu, L. AU - Yuan, H. AU - Fang, J. AU - Cheng, L. AU - Zheng, X. AU - Wang, X. PY - 2017 DA - 2017// TI - WBSCR22 confers oxaliplatin resistance in human colorectal cancer JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-15749-z DO - 10.1038/s41598-017-15749-z ID - Yan2017 ER - TY - JOUR AU - Kemeny, N. AU - Garay, C. A. AU - Gurtler, J. AU - Hochster, H. AU - Kennedy, P. AU - Benson, A. AU - Brandt, D. S. AU - Polikoff, J. AU - Wertheim, M. AU - Shumaker, G. PY - 2004 DA - 2004// TI - Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.03.119 DO - 10.1200/JCO.2004.03.119 ID - Kemeny2004 ER - TY - JOUR AU - McKeand, W. PY - 2017 DA - 2017// TI - Pharmacokinetics, dose proportionality, and bioavailability of Bazedoxifene in healthy postmenopausal women JO - Clin Ther VL - 39 UR - https://doi.org/10.1016/j.clinthera.2017.07.012 DO - 10.1016/j.clinthera.2017.07.012 ID - McKeand2017 ER - TY - JOUR AU - Nair, A. B. AU - Jacob, S. PY - 2016 DA - 2016// TI - A simple practice guide for dose conversion between animals and human JO - J Basic Clin Pharm VL - 7 UR - https://doi.org/10.4103/0976-0105.177703 DO - 10.4103/0976-0105.177703 ID - Nair2016 ER -